Jun 2026 (Q2 FY26) — Jul 31, 2026
Eastman Q2 FY26 — Strong Specialty Performance and Circular Growth Amidst Weak End Markets
Read the full callEastman earnings: last reported Fri, 31 Jul 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 2,513 | +9.9% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | 183 | +30.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
1Y: $61.28 on 17 Oct 2025 → $62.48. High $81.36 (11 Feb 2026), low $56.37 (20 Nov 2025).
Overview
Call summaries
Eastman Q2 FY26 — Strong Specialty Performance and Circular Growth Amidst Weak End Markets
Read the full callEvery analysed call
Financials
Net profit, year on year: +31% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,464 | 2,245 | 2,290 | 2,287 | 2,202 | 1,973 | 2,177 | 2,513 |
| Other income | -3 | -5 | -8 | -49 | -3 | -24 | -13 | -14 |
| Profit before tax | 280 | 297 | 253 | 169 | 134 | 12 | 136 | 256 |
| Tax rate | 35.4% | −11.4% | 27.7% | 17.2% | 64.9% | −775.0% | 21.3% | 28.1% |
| Net profit | 180 | 330 | 182 | 140 | 47 | 105 | 107 | 183 |
| EPS ($ per share) | 1.55 | — | 1.58 | 1.22 | 0.41 | — | 0.93 | 1.60 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Reserves | 7,573 | 7,965 | 8,080 | 8,557 | 8,973 | 9,490 | 10,013 | 10,105 |
| Total liabilities | 10,117 | 9,976 | 9,975 | 9,731 | 9,431 | 9,103 | 9,361 | 8,822 |
| Fixed assets | 5,600 | 5,571 | 5,549 | 4,996 | 5,160 | 5,548 | 5,615 | 5,731 |
| Total assets | 15,995 | 16,008 | 16,083 | 15,519 | 14,667 | 14,633 | 15,213 | 14,859 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1,543 | 1,504 | 1,455 | 1,619 | 975 | 1,374 | 1,287 | 970 |
| Cash from investing | -463 | -480 | -394 | -29 | 392 | -432 | -534 | -462 |
| Cash from financing | -1,040 | -1,043 | -704 | -1,690 | -1,321 | -888 | -454 | -797 |
| Net cash flow | — | — | 360 | -105 | 34 | 55 | 289 | -271 |
| Capital expenditure | -528 | -425 | -383 | -555 | -611 | -828 | -599 | -546 |
| Free cash flow | 1,015 | 1,079 | 1,072 | 1,064 | 364 | 546 | 688 | 424 |
Fibers shrank from 14% to 10% of revenue over the last two years.
| Segment | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Advanced Materials | 32% | 32% | 31% | 34% | 33% | 33% | — | 33% | +5.1% |
| Additives and Functional Products | 30% | 31% | 32% | 34% | 33% | 34% | 34% | 32% | +4.9% |
| Chemical Intermediates | 24% | 22% | 24% | 20% | 23% | 21% | 23% | 26% | +38.9% |
| Fibers | 14% | 14% | 13% | 12% | 12% | 12% | 10% | 10% | -11.3% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
35 filings between Feb 4, 2026 and Sep 2, 2026.
Purchases
None
No insider bought shares.
Sales
$365.8K
2 sales by 1 insider
Also filed: 3 gifts.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Holt Adrian James | — | $365.8K | Aug 4, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | OBRIEN JAMES J /KY Director | Gift | 2,482 | $0 |
| Sep 2, 2026 | OBRIEN JAMES J /KY Director | Gift | 5,378 | $0 |
| Sep 2, 2026 | OBRIEN JAMES J /KY Director | Gift | 7,860 | $0 |
| Aug 4, 2026 | Holt Adrian James SVP, Chf HR Ofcr | Sale | 3,283 | $234.1K |
| Jun 1, 2026 | Holt Adrian James SVP, Chf HR Ofcr | Award | 4,341 | — |
| Jun 1, 2026 | Holt Adrian James SVP, Chf HR Ofcr | Tax withheld | 1,058 | $79.9K |
| May 7, 2026 | OBRIEN JAMES J /KY Director | Award | 1,628 | $0 |
| May 7, 2026 | HORNBAKER RENEE J Director | Award | 1,628 | $0 |
| May 7, 2026 | Haynesworth Linnie M Director | Award | 1,628 | $0 |
| May 7, 2026 | SLAGER DONALD W Director | Award | 1,628 | $0 |
| May 7, 2026 | Holder Julie Fasone Director | Award | 1,628 | $0 |
| May 7, 2026 | BUTLER ERIC L Director | Award | 1,628 | $0 |
| May 5, 2026 | Holt Adrian James SVP, Chf HR Ofcr | Sale | 1,709 | $131.7K |
| Feb 18, 2026 | Stewart Michelle Renee Controller & CAO | Tax withheld | 1,063 | $85.3K |
| Feb 18, 2026 | McLain William Thomas Jr. EVP, CFO | Tax withheld | 4,471 | $358.8K |
| Feb 18, 2026 | Costa Mark J CEO & Board Chair | Tax withheld | 25,260 | $2.03M |
| Feb 18, 2026 | McAlindon Julie A. SVP, Regions & Chf SupChn Ofcr | Tax withheld | 1,812 | $145.4K |
| Feb 18, 2026 | Caveness Michelle H SVP & Chf. Mfg. Ofc. | Tax withheld | 528 | $42.4K |
| Feb 18, 2026 | LICH BRAD A EVP & CCO | Tax withheld | 5,569 | $447.0K |
| Feb 18, 2026 | CRAWFORD STEPHEN GLENN EVP, Chief Tech and Sust. Ofc. | Tax withheld | 4,720 | $378.8K |
| Feb 18, 2026 | Holt Adrian James SVP, Chf HR Ofcr | Tax withheld | 588 | $47.2K |
| Feb 18, 2026 | SMITH BRIAN TRAVIS EVP, AFP, Mfg., WWEC & HSE | Tax withheld | 3,086 | $247.7K |
| Feb 11, 2026 | SMITH BRIAN TRAVIS EVP, AFP, Mfg., WWEC & HSE | Award | 10,589 | $0 |
| Feb 11, 2026 | LICH BRAD A EVP & CCO | Award | 18,861 | $0 |
| Feb 11, 2026 | McLain William Thomas Jr. EVP, CFO | Award | 15,883 | $0 |
| Feb 11, 2026 | CRAWFORD STEPHEN GLENN EVP, Chief Tech and Sust. Ofc. | Award | 12,133 | $0 |
| Feb 11, 2026 | Stewart Michelle Renee Controller & CAO | Award | 3,309 | $0 |
| Feb 11, 2026 | Caveness Michelle H SVP & Chf. Mfg. Ofc. | Award | 1,937 | $0 |
| Feb 11, 2026 | McAlindon Julie A. SVP, Regions & Chf SupChn Ofcr | Award | 7,280 | $0 |
| Feb 11, 2026 | Costa Mark J CEO & Board Chair | Award | 64,192 | $0 |
| Feb 11, 2026 | Holt Adrian James SVP, Chf HR Ofcr | Award | 2,297 | $0 |
| Feb 4, 2026 | McLain William Thomas Jr. EVP, CFO | Option exercise | 3,013 | $196.3K |
| Feb 4, 2026 | Costa Mark J CEO & Board Chair | Tax withheld | 43,638 | $3.43M |
| Feb 4, 2026 | McLain William Thomas Jr. EVP, CFO | Tax withheld | 2,636 | $206.9K |
| Feb 4, 2026 | Costa Mark J CEO & Board Chair | Option exercise | 48,649 | $3.17M |
| Oct 1, 2025 | Caveness Michelle H SVP & Chf. Mfg. Ofc. | Option exercise | 6,715 | — |
| Oct 1, 2025 | Caveness Michelle H SVP & Chf. Mfg. Ofc. | Tax withheld | 1,636 | $101.4K |
| Aug 27, 2025 | SMITH BRIAN TRAVIS EVP, AFP, Mfg., WWEC & HSE | Purchase | 1,750 | $119.6K |
| Aug 27, 2025 | BEGEMANN BRETT D Director | Purchase | 1,500 | $102.4K |
| Aug 27, 2025 | McLain William Thomas Jr. EVP, CFO | Purchase | 3,670 | $252.2K |
| Aug 27, 2025 | LICH BRAD A EVP & CCO | Purchase | 3,280 | $224.6K |
| Aug 27, 2025 | Holder Julie Fasone Director | Purchase | 1,453 | $100.0K |
| Aug 27, 2025 | Audia Damon J Director | Purchase | 1,465 | $100.5K |
| Aug 27, 2025 | Costa Mark J CEO & Board Chair | Purchase | 7,400 | $502.4K |
| Aug 27, 2025 | McAlindon Julie A. SVP, Regions & Chf SupChn Ofcr | Purchase | 2,000 | $136.9K |
| Aug 27, 2025 | BUTLER ERIC L Director | Purchase | 3,000 | $206.0K |
| Aug 27, 2025 | OBRIEN JAMES J /KY Director | Purchase | 1,450 | $99.8K |
| Aug 27, 2025 | Mink Kim Ann Director | Purchase | 1,450 | $100.6K |
| May 1, 2025 | Holder Julie Fasone Director | Award | 1,575 | $0 |
| May 1, 2025 | OBRIEN JAMES J /KY Director | Award | 1,575 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow EASTMAN CHEMICAL CO and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading